UBS raises Insulet target price to $171 from $150
PODD•UBS raised its target price for Insulet to $171 from $150.
Related News
UBS raises Clover Health target price to $5.5 from $5
CLOV•
People Incorporated: UBS cuts target price to $45 from $56
PPLI•
Edwards Lifesciences target price raised to $118 from $110 by UBS
EW•
UBS cuts Flutter Entertainment target price to $120 from $130
FLUT•
Tripadvisor CEO Goldberg to step down as travel firm pushes overhaul
TRIP•